Insider filing · LQDA

Paul B Manning sold $12.8M of Liquidia (LQDA)

Executed Jun 4, disclosed Jun 8, 4 days later.

Returns are measured on stock purchases only.

PM Paul B Manning Director profile →

Paul B Manning (Director) filed 3 Form 4 reports in the trailing twelve months (2 purchases, 1 sale, 1 filed past the two-business-day deadline), most often in Candel Therapeutics, Inc. (CADL). Across 2 priced purchase filings, the average 21-session return was +36.0% from execution and +33.7% from disclosure (delay-adjusted; derived). The largest single filing was $17.5M of VRCA (4,126,142 sh across 2 lots, as filed), executed Nov 25 2025.

LQDA Liquidia Corporation LQDA · Healthcare · 93 filings in 24 months ticker →

Healthcare · Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for rare cardiopulmonary dis…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→